Jiacong Guo
Executive Director @ BioTrack Capital
Shanghai, China
Jiacong Guo is a seed investor at BioTrack Capital in Shanghai focused on Biotechnology and Pharmaceutical. Jiacong Guo
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Jiacong Guo invests in
Stages Jiacong Guo invests in
Countries Jiacong Guo invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Pharmaceutical 2 (67%)
- Oncology 1 (33%)
- Biopharma 1 (33%)
- Health Care 1 (33%)
Stage
- Seed 1 (33%)
- Angel 1 (33%)
- Series A 1 (33%)
Country
- China 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OnCusp Therapeutics
|
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancerpatients around the world.It is founded by Bing Yuan, Eric Slosberg, and Andy Fu. | $100M / Series A / Jan 04, 2024 | |
Brise Pharma
|
Brise Pharma operates in the scientific research and technical service industry. | $23.3M / Angel / Oct 01, 2021 | |
|
OnCusp Therapeutics
|
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancerpatients around the world.It is founded by Bing Yuan, Eric Slosberg, and Andy Fu. | $25M / Seed / Apr 01, 2021 |
Co-Investors
Qiming Venture Partners
2 deals together
BioTrack Capital
1 deal together
Blackbird Ventures
1 deal together
Catalio Capital Management
1 deal together
About BioTrack Capital
BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.
BioTrack Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Feng Tao
Co-Founder & Partner
|
|||
|
Jiacong Guo
Executive Director
|
|||
Kevin (Penghui) Chen
Founder & Partner
|
|||
|
Zhang Ye
Project Manager
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jiacong Guo invest in?
Jiacong Guo invests primarily in Biotechnology, Pharmaceutical and Oncology startups, most often at Seed and Angel stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jiacong Guo last invest?
The most recent investment recorded for Jiacong Guo closed in Jan 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
